Wednesday, February 25, 2026
News Health

News Health

Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk in individuals with schizophrenia spectrum disorders compared with placebo. Medscape Medical News Source link : https://www.medscape.com/viewarticle/semaglutide-lowers-antipsychotic-related-cardiometabolic-2025a1000yxa?src=rss Author...

Read more
Page 131 of 160 1 130 131 132 160

Categories

Archives

February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728